Nataliya Fesenko

1PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 15, 2023
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer.

Sandra J Casak, M Naomi Horiba, Mengdie Yuan

Pageof 1

Frequent Collaborators

1 joint publications

Sandra J Casak

1 joint publications

M Naomi Horiba

1 joint publications

Mengdie Yuan

1 joint publications

Joyce Cheng